AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

Issue

Thursday, September 19, 2019


In The News


Asymptomatic patients with head trauma often fly under the radar of clinicians. Without proper treatment and diagnosis, they can suffer more long-term injuries over time. Two studies zeroed in on undetected brain traumas, leveraging blood biomarkers such as glial fibrillary acidic protein (GFAP) to flag concussion.
Under the right circumstances, self-monitoring with continuous glucose monitoring (CGM) can inform care for patients on intense insulin regimens. The American Diabetes Association (ADA) made this key recommendation and others regarding CGM and automated insulin delivery systems in an update to its Standards of Medical Care.
Versatile for a number of clinical uses, liquid biopsy is making headway as a personalized cancer screening device. In a study published in Science Translational Medicine (STM), a highly sensitive liquid biopsy test known as targeted digital sequencing (TARDIS) identified fragments of circulating tumor DNA (ctDNA) as low as 2…

AACC Alert


Two sessions at AACC’s premier preanalytical conference, Optimizing Quality in the Clinical Laboratory: Focus on the Preanalytical Phase, delve into the importance of stakeholder communication and identifying and managing interferences to reduce errors in this challenging phase of laboratory science. Conference attendees will learn about best practices and approaches to…

Inside AACC


AACC boot camps on point-of-care testing (POCT) offer unique, interactive experiences to help POCT professionals improve their programs. This year’s regional conference in Pittsburgh, 2019 Point of Care Testing Boot Camp and Beyond: Communicating, Connecting, and Collaborating, places a specific emphasis on skills and tools that will enable POCT staff…

World View


Bone turnover markers (BTMs) are gaining traction as a tool for identifying osteoporosis in its earliest stages, as well as providing key information for monitoring and treating patients with the disease. Updating its 2012 guidance, the Japan Osteoporosis Society offers a detailed tutorial on the types of assays and algorithms…